Our Partners

RSS Investor Relations and News

  • MYOS RENS Technology Announces Approval of $1.2 Million in NJEDA NOL Program Tax Credits December 06, 2018
    Net Proceeds of $1.1 Million in Non-dilutive Funding Expected CEDAR KNOLLS, N.J., Dec. 6, 2018 /PRNewswire/ -- MYOS RENS Technology Inc. ("MYOS" or "the Company") (NASDAQ: MYOS), a biotherapeutics and bionutrition company and the owner of Fortetropin®, a proprietary bioactive composition derived from fertilized egg yolk that helps build lean [...]
    MYOS RENS Technology Reports Financial Results for the Third Quarter of 2018 and Business Updates November 14, 2018
    Conference Call to be Held Thursday, November 15, 2018, at 10:30am ET CEDAR KNOLLS, N.J., Nov. 14, 2018 /PRNewswire/ -- MYOS RENS Technology Inc. ("MYOS" or "the Company") (NASDAQ: MYOS), a bionutrition company and owner of Fortetropin®, the natural food product that helps build lean muscle in conjunction with resistance training, [...]
    Learn More ›
  • 2018 Annual Meeting of Stockholders

    45 Horsehill Road, Suite 106, Cedar Knolls, New Jersey 07927

    Q3 2018 Financial Results Conference Call

    A replay is available until February 9, 2019 and may be accessed by dialing 877-660-6853 from the U.S. or 201-612-7415 for international callers, using the Conference ID# 13684940.


Stock Snapshot

MYOS Symbol
Market Cap